Chinese team develops 'smart' diabetes probiotic to rival Ozempic

A Chinese research team has developed an engineered probiotic, named Gift, designed to manage diabetes. This probiotic can detect high blood sugar levels and automatically release the hormone GLP-1, which lowers blood glucose. In animal trials, Gift demonstrated efficacy comparable to the drug Ozempic. The team aims to make this probiotic available as a health supplement in the United States within two years, pending successful scaling of production and regulatory approval. AI

IMPACT This development could signal a new frontier in personalized medicine, leveraging engineered biological systems for therapeutic purposes.

RANK_REASON Development of a novel probiotic with potential to rival established pharmaceutical treatments for a major health condition. [lever_c_demoted from significant: ic=1 ai=0.4]

Read on SCMP — Tech →

• China Science Daily
• East China Normal University
• gift
• GLP-1
• Nature
• Ozempic
• Shanghai
• United States
• Ye Haifeng

• product
• paper
• other

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →